Company Filing History:
Years Active: 2014
Title: Innovations of Mei-Hsiu Liao in Radioactive Medicine
Introduction
Mei-Hsiu Liao is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of radioactive medicine, particularly in improving the efficiency and quality of chemical products used in medical applications. With a total of 2 patents, Liao's work has the potential to enhance the production processes in this critical area of healthcare.
Latest Patents
One of Liao's latest patents is a method for improving the purity and yield of chemical products in an automatic radioactive medicine synthesis system. This invention increases the number of target reaction containers from one to many, which, when coordinated with increased reaction times, results in a higher total reaction volume. By modifying an affinitive column of the automatic synthesis system, the production in a single batch is significantly increased. The products obtained from this method conform to quality check specifications while also saving costs.
Another significant patent by Liao involves a direct solid sample analytical technology for determining the content and uniformity in a lyophilized kit of a sulfur-containing chelator. This chelator has a stable complex capacity for radiotechnetium (Tc-99m) and radiorhenium (Re-186, Re-188). The invention utilizes an economical and stable coal standard as a contrast substance to construct a sulfur calibration curve. This allows for the determination of sulfur content and uniformity in the solid lyophilized sample, ensuring quality control of active pharmaceutical ingredients during key production processes and clinical applications.
Career Highlights
Mei-Hsiu Liao has worked with the Institute of Nuclear Energy Research and the Atomic Energy Council, where he has contributed to various projects aimed at advancing nuclear energy applications in medicine. His expertise in this field has positioned him as a valuable asset in the development of innovative solutions for radioactive medicine.
Collaborations
Liao has collaborated with notable colleagues, including Lie-Hang Shen and Chia-Jung Chang, who have contributed to his research and development efforts in the field.
Conclusion
Mei-Hsiu Liao's innovations in radioactive medicine demonstrate his commitment to enhancing the quality and efficiency of medical applications. His patents reflect a deep understanding of the complexities involved in chemical synthesis and quality control, making him a significant figure in the field.